Alzheimer’s disease is the most common type of dementia in the United States, impacting around 6.2 million people above the age of 65. Since it was ...
Continue readingAccelerating clinical studies is a mission that affects us all.
Alzheimer’s disease is the most common type of dementia in the United States, impacting around 6.2 million people above the age of 65. Since it was ...
Continue readingAs a digital company, Antidote does not produce goods or services that have a major environmental impact — however, we understand that small changes ...
Continue readingAntidote is dedicated to accelerating medical research by bringing sponsors and patients together. Through our clinical trial matching software, ...
Continue readingBefore becoming available to patients, every medication, therapy, and intervention must undergo a rigorous approval process: the clinical trial. ...
Continue readingGenerally, a doctor’s visit is intended to provide clarity and insight into a patient’s concerns — but many people are all too familiar with the ...
Continue readingThough clinical trials as we know them have only existed since the 1980s, the past 40 years have been ripe with innovations in the process. From an ...
Continue readingAntidote’s robust partner network, consisting of over 300 organizations, is made up of patient advocacy groups, point-of-care-companies, health ...
Continue readingHunter syndrome and Hurler syndrome are similar conditions with similar names — and as such, they are often confused. Both Hunter syndrome and Hurler ...
Continue readingAt Antidote, we consider the patient voice in how we think about the entire clinical trial process. From recruitment to randomization, the patient ...
Continue readingThough nephropathy and neuropathy are two medical terms that sound similar, they refer to conditions that are very different. Nephropathy is a term ...
Continue reading